Philadelphia Inquirer 04.02.19 Pancreatic cancer treatments show promise in studies, Penn reports Read
Medicine Matters Oncology 04.02.19 Researcher comment: The impact of lifestyle factors on the gut microbiome and immunotherapy response Read
The Week 04.01.19 New pancreatic cancer drug regimen shows ‘impressive’ results in clinical trial Read
STAT News 04.01.19 The Parker Institute touts early results in pancreatic cancer trial — and a new model to accelerate drug development Read
FierceBiotech 04.01.19 AACR: Apexigen, BMS steal the show with promising I-O combo in pancreatic cancer Read
BioPharma Dive 04.01.19 Despite research boom, few immunotherapy studies targeting pancreatic cancer Read
HemOnc Today 04.01.19 Immunotherapy, chemotherapy combination shows promising antitumor activity in metastatic pancreatic cancer Read
Endpoints News 03.29.19 After a 33-year odyssey, Jeffrey Bluestone grabs a ringside seat to watch his drug teplizumab go back into the clinic Read
The ASCO Post 03.08.19 A Single Dose of a PD-1 Inhibitor Before Surgery May Predict Outcomes in Patients With Melanoma Read